Validating an Indolent Non-Hodgkin’s Lymphoma (NHL) Cost-Effectiveness Analysis Model Using Two Software Tools- Key Implementation Considerations and Results
Nov 1, 2013, 00:00
10.1016/j.jval.2013.08.1635
https://www.valueinhealthjournal.com/article/S1098-3015(13)03540-7/fulltext
Title :
Validating an Indolent Non-Hodgkin’s Lymphoma (NHL) Cost-Effectiveness Analysis Model Using Two Software Tools- Key Implementation Considerations and Results
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)03540-7&doi=10.1016/j.jval.2013.08.1635
First page :
A589
Section Title :
Research on Methods Studies
Open access? :
No
Section Order :
1478